Connors Investor Services Inc Novartis Ag Transaction History

Connors Investor Services Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $203,580 - $250,560	-2,700 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$75.32 - $86.15 $37,660 - $43,075	-500 Reduced 15.63%	2,700 $260,000
Q4 2018 Feb 13, 2019	SELL	$73.66 - $82.02 $76,385 - $85,054	-1,037 Reduced 24.47%	3,200 $275,000
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $69,416 - $80,294	1,037 Added 32.41%	4,237 $365,000
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $237,248 - $247,264	3,200	3,200 $275,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Connors Investor Services Inc, based on Form 13F filings with the SEC.

Stay updated on Connors Investor Services Inc with notifications on news.